CYAD - Celyad Oncology appoints former exec as CEO

March, 24 2023 05:40 AM Celyad SA

2023-03-24 05:40:01 ET

Celyad Oncology ( NASDAQ: CYAD ) appointed Georges Rawadi as CEO, effective March 23, but would start on April 17.
Michel Lussier will continue to serve as interim CEO until April 17 to help with the transition, according to the company.
Rawadi had worked for Celyad for four years, between 2014 and 2018. Rawadi currently holds certain board positions and consultancy roles in the biotechnology industry.
The company noted that recently Rawadi served as CEO and board member of Ysopia Bioscience (France), vice-president BD & IP of Celyad and vice-president Business Development of Cellectis.
"His in-depth expertise in the CAR-T space and his significant BD and IP expertise are great assets that will help Celyad Oncology to excel in its next phase of growth," said Hilde Windels, chair of board.
On Thursday, Celyad had reported its FY22 results.

For further details see: